^
    Apply
    A Phase I Study of LX-039 Tablets (NCT04097756)
    Phase 1
    Shandong Luoxin Pharmaceutical Group Stock Co.,...
    Completed
    Last update posted :
    05/01/2023
    Initiation :
    01/07/2020
    Primary completion :
    08/08/2022
    Completion :
    02/07/2023
    HER-2 • ER
    |
    ER positive
    |
    LX-039